
Peptides et Protéines
3133 produits trouvés pour "Peptides et Protéines"
13C6-Lys Octreotide Trifluoroacetate
CAS :Produit contrôléFormule :C4313C6H66N10O10S2•xC2HF3O2Couleur et forme :White To Off-WhiteMasse moléculaire :1025.2011402Thyroxine Sodium Salt
CAS :Produit contrôléStability Hygroscopic
Applications One of the thyroid hormones involved in the maintenance of metabolic homeostasis. Synthesized and stored as amino acid residues of thyroglobulin, the major protein component of the thyroid follicular colloid. Synthesis and secretion are regulated by the pituitary hormone (TSH). Deiodinated in peripheral tissues to the active metabolite, liothyronine. The D-form has very little activity as a thyroid hormone, but has been used to treat hyperlipidemia.
References Post, A., et al.: Anal. Profiles Drug Subs., 5, 225 (1976), Nelson, J.C., et al.: Clin. Chem., 34, 1737 (1988), Fischer, D.A., et al.: Clin. Chem., 42, 135 (1996), Cavalieri, R.R., et al.: Thyroid, 7, 177 (1997),Formule :C15H10I4NO4·NaCouleur et forme :NeatMasse moléculaire :798.85Sugammadex Sodium-deuterated
CAS :Produit contrôléApplications Sugammadex Sodium-deuterated, is the labaled analogue of Sugammadex Sodium (S698100), which is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits.
References Welliver, M., et al.: Drug Des. Devel. Ther., 2, 49 (2008);Formule :C72H104Na8O48S8forundeuteratedCouleur et forme :NeatMasse moléculaire :2178.006Thyroxine Methyl Ester
CAS :Produit contrôléApplications Thyroxine Methyl Ester is the methyl ester analog of Thyroxine (T425600) with high cross reactivity with thyroxine-specific monoclonal antibodies of humans and lab animals. It is an inhibitor of malate dehydrogenase.Thyroxine Methyl Ester is suitable for malate dehydrogenase (MDH) related research.
References Mpoko, C.N. et al.: Clin. Chim. Acta, 146, 215 (1985); Maggio, E.T. et al.: Biochim. Biophys. Acta Enzymol., 522, 284 (1978);Formule :C16H13I4NO4Couleur et forme :NeatMasse moléculaire :790.9Teduglutide Trifluoroacetic Acid Salt
Applications Teduglutide TFA Salt is a polypeptide consisting of 33 amino acids. It is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.
References Jeppesen, P., et al.: Gut, 54, 1224 (2005)Formule :C164H252N44O55S•x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :3752.13 + x(114.02)(1S,2S)-Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity G
Stability Hygroscopic
Applications (1S,2S)-Bortezomib is an isomer of Bortezomib (B675700), proteasome inhibitor. (1S,2S)-Bortezomib has been seen to inhibit serine proteases shown to lower cellular Aβ concentrations, associated with Alzheimer’s or hypertension.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Hardy, J. et al.: Science, 297, 353 (2002); Paris, D. et al.: Mol. Med. 17, 149 (2011);Formule :C19H25BN4O4Couleur et forme :NeatMasse moléculaire :384.24Glucagon-d9 Trifluoroacetate
CAS :Produit contrôléFormule :C153H216D9N43O49Sx(C2HF3O2)Couleur et forme :NeatMasse moléculaire :3491.8Methionine
CAS :Methionine (D-Methionine) (MRX-1024; D-Methionine) is an effective chemoprotective agent which can also inhibit the neuronal activity through GABAA receptorFormule :C5H11NO2SDegré de pureté :99.13% - 99.62%Couleur et forme :SolidMasse moléculaire :149.21Oxytocin Acetate
CAS :Applications Oxytocin Acetate is the principal uterus-contracting and lactation-stimulating hormone of the posterior pituitary gland.
References Pierce, et al.: J. Biol. Chem., 199, 929 (1952), Tuppy, et al.: Biochem. Biophys. Acta, 11, 449 (1953), Cash, et al.: J. Med. Pharm. Chem., 5, 413 (1962), Nachtmann, F., et al.: Anal. Profiles Drug Subs., 10, 563 (1981),Formule :C43H66N12O12S2·C2H4O2Couleur et forme :White To Off-WhiteMasse moléculaire :1067.24N-Glycylproline
CAS :Applications N-Glycylproline was found to exhibit anti-ischemic effects on the metabolism of neuroactive amino acids and indices of energy turnover in the neocortex of rats after experimental brain ischemia.
References Bashun, Z.N., et al.: Neurochem. J., 7, 39 (2013);Formule :C7H12N2O3Couleur et forme :NeatMasse moléculaire :172.1825-9-Leuprolide xTFA Salt
CAS :Produit contrôléApplications 5-9-Leuprolide is a metabolite of Leuprolide (L330590), a gonadotropin-releasing hormone (GnRH) analogue acting as an agonist at pituitary GnRH receptors.
References Handelsman, David J., et al.: J. of Steroid Biochem. and Mol. Bio., 141, 113-120 (2014);Okada, Hiroaki, et al.: Pharma. Res., 8(6), 787-91 (1991)Formule :C34H57N9O6·x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :801.9Protoporphyrin-9
CAS :Stability Light Sensitive
Applications Protoporphyrin-9 is the precursor to heme sites and chlorophyll.Formule :C34H34N4O4Couleur et forme :NeatMasse moléculaire :562.66Lisinopril Cyclohexyl Analogue
CAS :Produit contrôléImpurity Lisinopril EP Impurity F
Applications Lisinopril Cyclohexyl Analogue (Lisinopril EP Impurity F) is a Lisinopril (L468985) impurity.
References Paraskevas, G., et al.: J. Pharm. Biomed. Anal., 29, 865 (2002),Formule :C21H37N3O5Couleur et forme :NeatMasse moléculaire :411.54L-Valine-d8
CAS :Produit contrôléApplications Labelled analogue of L-Vailne. L-Valine is an essential amino acid and one of 20 proteinogenic amino acids. L-Valine cannot be manufactured by the body and must be acquired through diet or supplementation. L-valine is found in grains, dairy products, mushrooms, meats, peanuts and soy proteins. L-Valine has been used in studies to attenuate arrhythmias and induce hypotensive effects.
References Choi, C.W. et al.: Anim. Feed Sci. Technol., 102, 15 (2002); Kolarski, D. et al.: Krmiva, 30, 155 (1988); Oba, M. et al.: J. Dairy Sci., 93, 2044 (2010); Mitrega, K. et al.: Pharmacol. Res., 64, 218 (2011);Formule :C52H8H3NO2Couleur et forme :NeatMasse moléculaire :125.2GSK1904529A
CAS :GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .Formule :C44H47F2N9O5SDegré de pureté :98.2% - 99.76%Couleur et forme :SolidMasse moléculaire :851.96L-Thioproline
CAS :Applications L-Thioproline is used to create a monolayer on gold electrodes for the determination Copper(II). L-Thioproline has shown to be an effect inhibitor of proline absorption in Saccharomyces chevalieri.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Cui, X., et. al.: Sci. China Chem., 53, 257 (2010); Magana-Schwenchke, N., Schwencke, J.: BBA-Biomembranes, 173, 313 (1969)Formule :C4H7NO2SCouleur et forme :NeatMasse moléculaire :133.17Desisobutyl-n-butyl Bortezomib
CAS :Impurity Bortezomib N-Pentyl Impurity
Applications Desisobutyl-n-butyl Bortezomib is an impurity of Bortezomib (B675700). Bortezomib impurity 5.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Lin, G., et al.: J. Biol. Chem., 283, 34423 (2008);Formule :C19H25BN4O4Couleur et forme :NeatMasse moléculaire :384.24(2R,4R)-Sacubitril
CAS :Applications (2R,4R)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H29NO5Couleur et forme :NeatMasse moléculaire :411.491N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester
CAS :Applications Used for the synthesis of Bortezomib from L-phenylalanine via dipeptidyl boronic acid ester intermediates.
References Zhu, Y., et al.: J. Med. Chem., 52, 4192 (2009),Formule :C15H15N3O3Couleur et forme :NeatMasse moléculaire :285.3Lisinopril (S,S,R)-Diketopiperazine (~90%)
CAS :Impurity Lisinopril EP Impurity D
Stability Hygroscopic
Applications Lisinopril (S,S,R)-Diketopiperazine (Lisinopril EP Impurity D) is an impurity of Lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor (1).
References 1. Goa, K. et al.: Drugs. 1996 Oct;52(4):564-88.Formule :C21H29N3O4Degré de pureté :~90%Couleur et forme :White To Off-WhiteMasse moléculaire :387.474-Methylbenzenesulfonic Acid Monohydrate
CAS :Produit contrôléImpurity Lisinopril EP Impurity B/ Anastrozole EP Impurity F
Applications 4-Methylbenzenesulfonic Acid Monohydrate (Lisinopril EP Impurity B) is used in the synthesis of resveratrol. Also used in the synthesis of oxane derivatives as antimalarial agents.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Davis, M. et al.: Org. Prep. Proc. Int., 45, 304 (2013); Wang, X. et al.: J. Med. Chem., 56, 2547 (2013);Formule :C7H8O3S·H2OCouleur et forme :WhiteMasse moléculaire :190.223,3',5'-Triiodo-L-thyronine
CAS :Formule :C15H12I3NO4Couleur et forme :Light Beige To GreyMasse moléculaire :650.97β-Hydroxy Thyroxine (>90%)
CAS :Produit contrôléImpurity Levothyroxine beta-Hydroxy Impurity / Levothyroxine beta-Hydroxy T4 Impurity
Applications It has been prepared for testing as possible antithyroid. It showed some thyromimetic activity.
References Wawzone, S., et al.: J. Med. Chem., 6, 442 (1963),Formule :C15H11I4NO5Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :792.87Dihydro Cyclosporin A
CAS :Produit contrôléApplications A Cyclosporin A (C988900) analog, an immunosuppressant.
References Emmer, G., et al.: J. Med. Chem., 37, 1918 (1994), High, K., et al.: J. Biol. Chem., 269, 9105 (1994),Formule :C62H113N11O12Couleur et forme :WhiteMasse moléculaire :1204.63(R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid
CAS :Produit contrôléApplications (R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, is an amino acid building block used in peptide synthesis. With a growing peptide drug market the fast, reliable synthesis of peptides is of great importance.
Formule :C10H11NO2Couleur et forme :NeatMasse moléculaire :177.2Sugammadex Sodium
CAS :Formule :C72H104O48S8·8NaCouleur et forme :White To BeigeMasse moléculaire :2178.00Bivalirudin Trifluoroacetic Acid Salt
CAS :Applications Bivalirudin Trifluoroacetic Acid Salt is an anticoagulant drug that is a direct thrombin inhibitor. It is used for treatment of acute coronary syndromes, and is a safer alternative to heparin due to lower rates of bleeding as an adverse effect of anticoagulant in patients.
References Stone, G., et al.: N. Engl. J. Med, 355, 2203 (2006); Stone, G., et al.: N Engl J Med, 358, 2218 (2008);Formule :C98H138N24O33·(C2HF3O2)xCouleur et forme :NeatMasse moléculaire :2180.2911402Bestatin
CAS :Bestatin (Ubenimex) competitively inhibits many aminopeptidases. Bestatin is a microbial metabolite and dipeptide with immunomodulatory and antitumor effects.Formule :C16H24N2O4Degré de pureté :98% - 99.63%Couleur et forme :White Crystalline PowderMasse moléculaire :308.37Ref: TM-T1257
2mg34,00€5mg52,00€10mg64,00€25mg99,00€50mg157,00€100mg222,00€200mg330,00€1mL*10mM (DMSO)58,00€L-Carnitine-L-tartrate
CAS :Produit contrôléApplications L-Carnitine-L-tartrate (cas# 36687-82-8) is a useful research chemical.
Formule :C7H16NO3·C4H4O6Couleur et forme :White To Off-WhiteMasse moléculaire :472.48(2S,4S)-Sacubitril
CAS :Stability Moisture Sensitive
Applications (2S,4S)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H29NO5Couleur et forme :NeatMasse moléculaire :411.49N-Formyl Thyroxine
CAS :Produit contrôléImpurity Levothyroxine N-Formyl Impurity; N-Formyl-T4 (USP)
Applications N-Formyl Thyroxine (Levothyroxine N-Formyl Impurity; N-Formyl-T4 (USP)) is a thyroxine derivative which showed less thyroid activity than Thyroxine Sodium (T425601).
References Basil, B., et al.: Br. J. Pharmacol. Chemother., 5, 315 (1950),Formule :C16H11I4NO5Couleur et forme :NeatMasse moléculaire :804.88Cyclosporin B
CAS :Applications An immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C61H109N11O12Degré de pureté :>80%Couleur et forme :NeatMasse moléculaire :1188.58Cyclosporin G
CAS :Produit contrôléFormule :C63H113N11O12Couleur et forme :NeatMasse moléculaire :1216.64N-Acetyl-L-methionine
CAS :Produit contrôléApplications N-Acetyl-L-methionine (CAS# 65-82-7) has been useful in the study of metabolic phenotypes of standard and cold-stored platelets.
References D’Alessandro, A., et al.: Transfusion (Malden, MA, US), 60, S96 (2020)Formule :C7H13NO3SCouleur et forme :NeatMasse moléculaire :191.00N-Acetyl-DL-methionine
CAS :Produit contrôléApplications C7H13NO3S (cas# 1115-47-5) is a useful research chemical.
Formule :C7H13NO3SCouleur et forme :NeatMasse moléculaire :191.25(R)-Lisinopril Sodium Salt
CAS :Applications R,S,S-Isomer of Lisinopril (L468985).
References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Formule :C21H31N3NaO5Couleur et forme :NeatMasse moléculaire :428.48rhPTH (1-30) Trifluoroacetic Acid Salt Hydrate
Produit contrôléImpurity Teriparatide Impurity
Applications A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 30 N-terminal residues of hPTH.
References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974);Formule :C157H260N48O46S2•x(C2HF3O2)•y(H2O)Couleur et forme :NeatMasse moléculaire :3620.171140218Sacubitril Calcium
CAS :Applications Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014)Formule :C24H28NOCa2Couleur et forme :NeatMasse moléculaire :430.52Cyclosporin H
CAS :Applications Cyclosporin is an immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C62H111N11O12Couleur et forme :NeatMasse moléculaire :1202.61L-Methionine-34S
CAS :Applications Labelled L-Methionine, an essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.
References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),Formule :C5H11NO234SCouleur et forme :NeatMasse moléculaire :151.11Boceprevir (>90%)
CAS :Produit contrôléFormule :C27H45N5O5Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :519.68(S)-Tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic Acid
CAS :Produit contrôléFormule :C9H16N2O3Couleur et forme :NeatMasse moléculaire :200.23Sacubitril Sodium Salt
CAS :Formule :C24H28NO5·NaCouleur et forme :White To Off-WhiteMasse moléculaire :433.473Glecaprevir
CAS :Produit contrôléApplications Glecaprevir is an antiviral drug used in the treatment of patients with hepatitis C virus (HCV) genotype 1-6, of special interest for the treatment of patients with chronic kidney disease also suffering from HCV.
References Kwo, P., et. al.: J. Hepatol, 67, 263 (2017)Gane, E., et. al.: N. Engl. J. Med, 377, 1448 (2017)Formule :C38H46F4N6O9SCouleur et forme :NeatMasse moléculaire :838.86(1R,3S)-Camphoric Acid
CAS :Applications (1R,3S)-Camphoric Acid is used primarily as a reagent in syntheses of crystalline structures. It is used in the preparation of polymeric transition metal dipyridylamine D-camphorate complexes.
References Blake, K. et al.: Crys. Growth Des., 12, 5215 (2012);Formule :C10H16O4Couleur et forme :White SolidMasse moléculaire :200.23N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS :Impurity Bortezomib USP Impurity B
Applications N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide is a metabolite of Bortezomib (B675700), a proteasome inhibitor for the treatment of multiple myeloma and is known to also target the ubiquitin-proteasome pathway.
References Pekol, T., et al.: Drug. Meta. Disp., 33, 771 (2005); Hsieh, F.Y., et al.: J. Pharma. Biomed. Anal., 49, 115 (2009);Formule :C14H14N4O2Couleur et forme :NeatMasse moléculaire :270.29Tabimorelin
CAS :Produit contrôléApplications NN703 (Tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily injections of GH. In vitro studies in human liver microsomes have indicated that NN703 is a mechanism-based inhibitor of CYP3A4.
References Fabre, G., et al.: Biochem. Pharmacol., 37, 4389 (1988), Thummel, K., et al.: Clin. Pharmacol. Ther., 59, 491 (1996), Yu, D., et al.: J. Clin. Pharmacol., 39, 1203 (1999),Formule :C32H40N4O3Couleur et forme :NeatMasse moléculaire :528.68Sacubitril
CAS :Formule :C24H29NO5Couleur et forme :Off-White To Light YellowMasse moléculaire :411.49N-Nitroso Lisinopril
CAS :Formule :C21H30N4O6Couleur et forme :White To Light YellowMasse moléculaire :434.486Carfilzomib (2R,4S)-Diol
CAS :Produit contrôléApplications Carfilzomib (2R,4S)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);Formule :C40H59N5O8Couleur et forme :NeatMasse moléculaire :737.93DL-Methionyl-DL-methionine
CAS :Produit contrôléFormule :C10H20N2O3S2Couleur et forme :NeatMasse moléculaire :280.4Perfluorophenol
CAS :Produit contrôléApplications Perfluorophenol is used in the synthesis of PGA-films as biodegradable polymers. It also participates in the synthesis of tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
References Lee, K. et al.: Langmuir., 20, 2531 (2004); Zhou, Z. et al.: Biomater., 34, 7683 (2013);Formule :C6HF5OCouleur et forme :NeatMasse moléculaire :184.06L-Valine-13C5,15N
CAS :Produit contrôléApplications Labelled analogue of L-Vailne. L-Valine is an essential amino acid and one of 20 proteinogenic amino acids. L-Valine cannot be manufactured by the body and must be acquired through diet or supplementation. L-valine is found in grains, dairy products, mushrooms, meats, peanuts and soy proteins. L-Valine has been used in studies to attenuate arrhythmias and induce hypotensive effects.
References Choi, C.W. et al.: Anim. Feed Sci. Technol., 102, 15 (2002); Kolarski, D. et al.: Krmiva, 30, 155 (1988); Oba, M. et al.: J. Dairy Sci., 93, 2044 (2010); Mitrega, K. et al.: Pharmacol. Res., 64, 218 (2011);Formule :C5H1115NO2Couleur et forme :NeatMasse moléculaire :123.1Bortezomib Trimer
CAS :Produit contrôléApplications Bortezomib Trimer is derived from Bortezomib (B675700), which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009)Formule :C57H69B3N12O9Couleur et forme :NeatMasse moléculaire :1098.666Sacubitril-d4
CAS :Produit contrôléApplications Isotope labelled Sacubitril is an antihypertensive drug used in combination with Valsartan (V095750). The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C242H4H25NO5Couleur et forme :Light YellowMasse moléculaire :415.52(R)-Hydroxy Des(boric Acid) Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity I
Applications (R)-Hydroxy Des(boric acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C. et al.: Chem. and Eng. News, 87, 41 (2009)Formule :C19H24N4O3Couleur et forme :NeatMasse moléculaire :356.42Bortezomib
CAS :Produit contrôléStability Hygroscopic and Moisture Sensitive
Applications Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H25BN4O4Couleur et forme :White To Off-WhiteMasse moléculaire :384.24Voclosporin-d4
CAS :Produit contrôléApplications Labelled Voclosporin (V678500). A new agent for the treatment of noninfectious uveitis. Uveitis is an inflammatory, putative Th1-mediated autoimmune disease that affects various parts of the eye and is a leading cause of visual loss. Voclosporin, a rationally designed novel calcineurin inhibitor, exhibits a favorable safety profile, a strong correlation between pharmacokinetic and pharmacodynamic response, and a wide therapeutic window. Immunosuppressant.
References Aspeslet, L., et al.: Transplant Proc., 33, 1048 (2001), Cho, M., et al.: Arthritis Rheum., 46, 1202 (2002), Staatz, C., et al.: Clin. Pharmacokinet., 43, 623 (2004),Formule :C63H107D4N11O12Couleur et forme :NeatMasse moléculaire :1218.65(2S,4R)-Sacubitril
CAS :Produit contrôléStability Temperature Sensitive
Applications (2S,4R)-Sacubitril is the enantiomer and an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H29NO5Couleur et forme :Colourless To Off-WhiteMasse moléculaire :411.49Cyclosporin AM 1
CAS :Produit contrôléApplications A cyclosporine metabolite specifically inhibits growth of renal cells in culture.
References Schultz, J.C.; et al.: Biochem. Pharma., 42, 1403 (1991), Johnson, B., et al.: Drug Metab. Dispos., 34, 556 (2006), Westley, I.S., Drug Metab. Dispos., 36, 46 (2008).Formule :C62H111N11O13Degré de pureté :>80%Couleur et forme :NeatMasse moléculaire :1218.61Gramicidin (Technical Grade)
CAS :Produit contrôléFormule :C99H140N20O17Couleur et forme :Off-WhiteMasse moléculaire :1882.3Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5)
CAS :Produit contrôléApplications Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5) is an isotopically labelled form of Teduglutide (T013795), which is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.
References Jeppesen, P., et al.: Gut, 54, 1224 (2005)
Chemical Name: Jeppesen, P., et al.: Gut, 54, 1224 (2005)Formule :C164H244D8N44O55S•C2HF3O2•x(H2O)Couleur et forme :NeatMasse moléculaire :3760.0811402183,3',5-Triiodo-L-thyronine
CAS :Produit contrôléFormule :C15H12I3NO4Couleur et forme :White To Off-WhiteMasse moléculaire :650.97L-Methionine [R,S]-Sulfoximine
CAS :Produit contrôléApplications Methionine sulfoximine inhibits both glutamine synthetase and g-glutamylcysteine synthetase. Working concentrations for inhibition of g-glutamylcysteine synthetase are 0.2-2.0 mM (52% inhibition occured at 100 mM).Methionine sulfoximine is also a toxic byproduct of nitrogen trichloride, a compound that was used to bleach unprocessed wheat flour prior to 1968. The compound has been investigated as a potential neurotoxin linked to diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson’s disease.
References Griffith, O.W., and Meister, A.: J. Biol. Chem. 254, 7558 (1979), Willard-Mack, C.L., et al: Neuroscience, 71, 2, 589 (1996)Formule :C5H12N2O3SCouleur et forme :NeatMasse moléculaire :180.23N-Pyrazinylcarbonyl-L-phenylalanine
CAS :Produit contrôléApplications Used for the synthesis of Bortezomib (B675700) from L-phenylalanine via dipeptidyl boronic acid ester intermediates.
References Zhu, Y., et al.: J. Med. Chem., 52, 4192 (2009),Formule :C14H13N3O3Couleur et forme :WhiteMasse moléculaire :271.27[Des-Thr-ol8]-[D-Cys7]-Octreotide TFA
CAS :Produit contrôléFormule :C45H57N9O9S2•x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :1046.15Methyl Benzenesulfonate
CAS :Produit contrôléApplications A sulfonate ester as potential genotoxic impurity in drug substances. It may exert genotoxic effects in bacterial and mammalian cell systems.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Eder, E., et al.: Xenobiotica, 12, 831 (1982), Li, W., et al.: J. Chromatogr., 1046, 297 (2004), Glowienke, S., et al.: Mutat. Res., 581, 23 (2005), Colon, I., et al.: J. Pharm. Biomed. Anal., 39, 477 (2005),Formule :C7H8O3SCouleur et forme :ColourlessMasse moléculaire :172.2L-Prolinamide
CAS :Applications Proline based organocatalyst.
References Alberg, D., et al.: Bioorg. Med. Chem. Lett., 19, 3888 (2009), Huang, X., et al.: J. Phys. Chem., 114, 1068 (2010),Formule :C5H10N2OCouleur et forme :White SolidMasse moléculaire :114.146(4R)-1-Methyl-4-propyl-L-proline Hydrochloride
CAS :Produit contrôléApplications Proline derivative, and an intermediate in the production of biosynthetic antibiotics.
Formule :C9H17NO2·ClHCouleur et forme :NeatMasse moléculaire :207.7MK 677
CAS :Applications MK-677 is a potent, non-peptide ghrelin receptor agonist.
References Kirstie, A., et al.: Mol. Pharmacol., 76, 802 (2009); Birgitte, H. et al.: Mol. Pharmacol., 75, 44 (2009)Formule :C27H36N4O5S·CH4SO3Couleur et forme :NeatMasse moléculaire :624.85-Oxo-DL-proline-d5
CAS :Produit contrôléApplications 5-Oxo-DL-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.
References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);Formule :C52H5H2NO3Couleur et forme :NeatMasse moléculaire :134.14Cyclosporin C
CAS :Produit contrôléApplications A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C62H111N11O13Degré de pureté :>80%Couleur et forme :NeatMasse moléculaire :1218.61N-Nitroso-D,L-proline-d3
CAS :Produit contrôléApplications A labelled nitrosoamino acid with oncogenic activity.
References Nagasawa, H.T., et al.: J. Med. Chem., 16, 583 (1973)Formule :C52H3H5N2O3Couleur et forme :Off-WhiteMasse moléculaire :147.147Daptomycin
CAS :Applications Daptomycin is a Cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formule :C72H101N17O26Couleur et forme :Light YellowMasse moléculaire :1620.674-(Phenylamino]-1-benzyl-4-piperidinecarboxylic Acid Methyl Ester
CAS :Produit contrôléApplications Remifentanil derivative.
References James, M.K., et al.: J. Pharmacol. Exp. Ther., 259, 712 (1991), Hoffman, W.E., et al.: Anesthesiology, 79, 107 (1993), Selinger, K., et al.: J. Pharm. Biomed. Anal., 12, 243 (1994), Richardson, T.D., et al.: Expert Opin. Drug Saf., 4, 643 (2005),Formule :C20H24N2O2Couleur et forme :NeatMasse moléculaire :324.41683,3’,5-Triiodo-D-thyronine
CAS :Produit contrôléApplications 3,3’,5-Triiodo-D-thyronine is a structural analogue o the thyroid homonef Thyroxine (T425600). 3,3’,5-Triiodo-D-thyronine has been shown to reduce cholesterol in blood serum.
References Mintz, D.O., et. al.: New Engl. J. Med., 266, 808 (1962)Formule :C15H12I3NO4Couleur et forme :Off-White To Light BrownMasse moléculaire :650.97(S)-Lisinopril Dimer
CAS :Produit contrôléApplications (S)-Lisinopril (L468985) impurity. Lisinopril Impurity G (Dimer Impurity)
Formule :C42H60N6O9Couleur et forme :WhiteMasse moléculaire :792.96D-Ser(8)-Semaglutide
D-Ser(8)-Semaglutide is a semaglutide impurity. The amino acid at position 8 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molDes-Glu(3)-Semaglutide
Des-Glu(3)-semaglutide is a semaglutide-related impurity. This des-amino acid form has got the glutamic acid or glutamate (Glu) amino acid from position 3 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Formule :C182H284N44O56Masse moléculaire :3,984.53 g/molD-Ser(11)-Semaglutide
D-Ser(11)-Semaglutide is a semaglutide impurity. The amino acid at position 11 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 54 (D-Ala 18)
D-Ala(18)-Semaglutide is a semaglutide impurity. The amino acid at position 18 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Thr(5)-Semaglutide
D-Thr(5)-Semaglutide is a semaglutide impurity. The amino acid at position 5 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molLinear Semaglutide
Linear semaglutide, or simply L-Sema, is the semaglutide compound without the lipid side chain modification. It is essentially a linear version of the peptide.Formule :C152H230N42O47Masse moléculaire :3,397.76 g/molD-Val(10)-Semaglutide
D-Val(10)-Semaglutide is a semaglutide impurity. The amino acid at position 10 has been replaced by the D-form of the amino acid D-valine (D-Val). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol3,3',5,5'-Tetraiodothyroformic acid
CAS :Cymit Quimicaetic beta-D-glucosiduronic acidFormule :C13H6I4O4Degré de pureté :Min. 95 Area-%Couleur et forme :Off-White PowderMasse moléculaire :733.8 g/molD-Asp(9)-Semaglutide
D-Asp(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the D-form of the amino acid D-aspartic acid (D-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.
Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 56 (D-Glu 21)
D-Glu(21)-Semaglutide is a semaglutide impurity. The amino acid at position 21 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol(S,E)-N-(1-(3-Methylbut-1-enylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS :R-N-(1-(3-methylbut-1-enyl)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide is a drug product that is used for the treatment of bacterial infections. The compound is an impurity in the synthesis of other compounds and is also used as an analytical standard. It is synthesized from commercially available starting materials and through custom synthesis. R-N-(1-(3-methylbut-1-enyl)-1--oxo--3--phenylpropan--2--yl)pyrazine--2--carboxamide has been shown to be metabolized by CYP450 enzymes, which are responsible for the metabolism of many drugs. R-(1-(3Methylbut 1Enylamino)-1Oxo 3Phenylpropan 2Yl)Pyrazine 2Carboxamide has not been evaluated as a drug product and therefore does notFormule :C19H22N4O2Degré de pureté :Min. 95%Masse moléculaire :338.4 g/molSemaglutide Impurity 59
D-Arg(28)-Semaglutide is a semaglutide impurity. The amino acid at position 28 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.
Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol(R)-3-Methyl-1-(pyrazine- 2-carboxamido)butylboronic acid
The compound is a drug product, analytical, and research material. The molecule has been synthesized and purified by the company's chemists. It is not an API impurity but an impurity standard for HPLC. This compound is a synthetic chemical that does not occur naturally in any living organism. It has been developed for use in drug development and research. The compound was custom synthesized by the company's chemists to meet customer demand for high purity standards of this compound. It is used as a pharmacopoeia standard for HPLC analysis and drug development.Degré de pureté :Min. 95%Semaglutide Impurity 101 (D-Glu 3)
D-Glu(3)-Semaglutide is a semaglutide impurity. The amino acid at position 3 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Ala(24)-Semaglutide
D-Ala(24)-Semaglutide is a semaglutide impurity. The amino acid at position 24 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 60 (D-Arg 30)
D-Arg(30)-Semaglutide is a semaglutide impurity. The amino acid at position 30 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-His(1)-Semaglutide
D-His(1)-Semaglutide is a semaglutide impurity. The amino acid at position 1 has been replaced by the D-form of the amino acid D-histidine (D-His). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molDes-His(1)-Semaglutide
Des-His(1)-semaglutide is a semaglutide-related impurity. This des-amino acid form has the histidine (His) amino acid from position 1 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Formule :C181H284N42O58Masse moléculaire :3,976.5 g/molSemaglutide Impurity 51 (D-Thr 7)
D-Thr(7)-Semaglutide is a semaglutide impurity. The amino acid at position 7 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 29 (β-Asp-9)
Beta-Asp-(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the beta-aspartic acid (also known as isoaspartic, isoAsp, β-Asp or beta-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Phe(6)-Semaglutide
D-Phe(6)-Semaglutide is a semaglutide impurity. The amino acid at position 6 has been replaced by the D-form of the amino acid D-phenylalanine (D-Phe). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol


